Year None20202019201820172016 December 30, 2020 Medicenna Establishes At-the-Market Sales Facility Go to December 9, 2020 Medicenna Announces Oral Presentation at the 2nd Annual Glioblastoma Drug Development Summit Go to December 2, 2020 Medicenna Hosting Key Opinion Leader Call on MDNA55 for the Treatment of Recurrent Glioblastoma Multiforme Go to November 23, 2020 Medicenna to Participate in Upcoming December Investor Conferences Go to November 18, 2020 Medicenna Announces Upcoming Oral Presentations at the 2020 Society for Neuro-Oncology Annual Meeting Go to November 13, 2020 Medicenna Reports Second Quarter Fiscal 2021 Financial Results and Operational Highlights Go to Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last »
December 9, 2020 Medicenna Announces Oral Presentation at the 2nd Annual Glioblastoma Drug Development Summit Go to
December 2, 2020 Medicenna Hosting Key Opinion Leader Call on MDNA55 for the Treatment of Recurrent Glioblastoma Multiforme Go to
November 18, 2020 Medicenna Announces Upcoming Oral Presentations at the 2020 Society for Neuro-Oncology Annual Meeting Go to
November 13, 2020 Medicenna Reports Second Quarter Fiscal 2021 Financial Results and Operational Highlights Go to
